Ekso Bionics Holdings, Inc. - stock earnings
EKSO Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| July 25, 2024 BeforeMarket | - / - | 5.3 million | - / 5.3 million | 5.3 million |
EKSO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -3.2 million USD | 4.8 million USD |
| 2023Q3 | -3.4 million USD | 4.6 million USD |
| 2023Q2 | -4.2 million USD | 4.7 million USD |
| 2023Q1 | -4.2 million USD | 4.1 million USD |
| 2022Q4 | -2.1 million USD | 3.6 million USD |
| 2022Q3 | -5.0 million USD | 3.3 million USD |
| 2022Q2 | -2.7 million USD | 3.5 million USD |
| 2022Q1 | -5.0 million USD | 2.6 million USD |
| 2021Q4 | -2.9 million USD | 4.1 million USD |
| 2021Q3 | -2.0 million USD | 3.0 million USD |
| 2021Q2 | -1.3 million USD | 2.2 million USD |
| 2021Q1 | -3.7 million USD | 1.9 million USD |
| 2020Q4 | -4.0 million USD | 2.3 million USD |
| 2020Q3 | 2.5 million USD | 2.9 million USD |
| 2020Q2 | -11.8 million USD | 2.3 million USD |
| 2020Q1 | -2.5 million USD | 1.5 million USD |
| 2019Q4 | -2.7 million USD | 3.7 million USD |
| 2019Q3 | 206000 USD | 3.3 million USD |
| 2019Q2 | -3.1 million USD | 3.3 million USD |
| 2019Q1 | -6.6 million USD | 3.6 million USD |
| 2018Q4 | -4.1 million USD | 3.3 million USD |
| 2018Q3 | -7.0 million USD | 2.6 million USD |
| 2018Q2 | -8.0 million USD | 3.0 million USD |
| 2018Q1 | -7.9 million USD | 2.5 million USD |
| 2017Q4 | -9.0 million USD | 2.5 million USD |
| 2017Q3 | -6.3 million USD | 1.6 million USD |
| 2017Q2 | -5.5 million USD | 1.9 million USD |
| 2017Q1 | -8.3 million USD | 1.4 million USD |
| 2016Q4 | -5.6 million USD | 2.6 million USD |
| 2016Q3 | -8.5 million USD | 1.6 million USD |
| 2016Q2 | -5.8 million USD | 1.6 million USD |
| 2016Q1 | -3.7 million USD | 8.5 million USD |
| 2015Q4 | -4.6 million USD | 1.9 million USD |
| 2015Q3 | -5.2 million USD | 2.9 million USD |
| 2015Q2 | -5.6 million USD | 2.1 million USD |
| 2015Q1 | -4.1 million USD | 1.7 million USD |
| 2014Q4 | -20.2 million USD | 1.5 million USD |
| 2014Q3 | 12.0 million USD | 1.6 million USD |
| 2014Q2 | 56.1 million USD | 1.2 million USD |
| 2014Q1 | -81.8 million USD | 1.1 million USD |
| 2013Q4 | -6075 USD | 788000 USD |
| 2013Q3 | -1493 USD | 834000 USD |
| 2013Q2 | -4368 USD | 984000 USD |
| 2013Q1 | -4368 USD | 696000 USD |
| 2012Q4 | -1777 USD | ? USD |
| 2012Q3 | -4895 USD | ? USD |
| 2012Q2 | -4895 USD | ? USD |
EKSO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -15.2 million USD | 18.3 million USD |
| 2022 | -14.6 million USD | 12.9 million USD |
| 2021 | -8.4 million USD | 11.2 million USD |
| 2020 | -17.0 million USD | 8.9 million USD |
| 2019 | -11.7 million USD | 13.9 million USD |
| 2018 | -27.0 million USD | 11.3 million USD |
| 2017 | -29.1 million USD | 7.4 million USD |
| 2016 | -23.5 million USD | 14.2 million USD |
| 2015 | -19.6 million USD | 8.7 million USD |
| 2014 | -33.8 million USD | 5.3 million USD |
| 2013 | -12292 USD | ? USD |
| 2012 | -12292 USD | ? USD |
EKSO
Price: $1.35
52 week price:
Earnings Per Share: -1.10 USD
P/E Ratio: -1.79
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 30100
Ebitda: -6.6 millionMarket Capitalization: 23.8 million